Equimune®
Equimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is approved by the APVMA for the treatment of Equine Respiratory Disease Complex (ERDC) of viral origin.
Settle®
Settle, mycobacterium cell wall fraction (MCWF) immunostimulant, is approved by the APVMA as an aid in the treatment of equine endometritis caused by Streptococcus zooepidemicus.
Change Country
If your country is not listed, please call us at 613-391-3837 or e‑mail sales@novavive.ca.
Australia
Canada
New Zealand
U.S.A.
United Arab Emirates